speb/financial-data huggingface dataset:
Financial ratios for HANA.L — annual report dated 2022-03-31
Total revenue: 26548684.210526314
Net income: 24752631.57894737
Capital expenditures: 0
Operating cash flow: 5223684.2105263155
Net tangible assets: 503765789.4736842
Owner earnings: 24752631.57894737
Return on net tangible assets (%): 4.913519753853869
Buffett classification: The Gruesome
Stock price: 0.024078947368421054
P/E ratio: 0.12430757792366574
Shares outstanding: 127785473
Book value: 503765789.4736842
P/B ratio: 0.0061078773968166085
Market cap (USD): 3076939.6788157895
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 6.690786539128711
Free cash flow (dilution-adjusted): 5223684.2105263155
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): 19.67586856321554
Rule of 40 score: 19.67586856321554
Financial ratios for HANA.L — annual report dated 2023-03-31
Total revenue: -12965432.098765431
Net income: -14885185.185185185
Capital expenditures: 0
Operating cash flow: 17849382.71604938
Net tangible assets: 453043209.87654316
Owner earnings: -14885185.185185185
Return on net tangible assets (%): -3.2855994440886738
Buffett classification: The Gruesome
Stock price: 0.020123456790123454
Shares outstanding: 127785473
Book value: 453043209.87654316
P/B ratio: 0.005676026896025507
Market cap (USD): 2571485.4443209874
Debt to equity: 0
Free cash flow (dilution-adjusted): 17849382.71604938
Buyback yield (%): 0
Retained earnings: 51809876.54320987
Capitalized R&D asset: 0
Revenue growth (%): -148.8364394858588
Rule of 40 score: -148.8364394858588
Financial ratios for HANA.L — annual report dated 2024-03-31
Total revenue: 117862025.31645569
Net income: 115724050.63291138
Capital expenditures: 0
Operating cash flow: -6712658.227848101
Net tangible assets: 575375949.3670886
Owner earnings: 115724050.63291138
Return on net tangible assets (%): 20.112771616576506
Buffett classification: The Gruesome
Stock price: 0.02531645569620253
P/E ratio: 0.02795508149023211
Shares outstanding: 127785473
Book value: 575375949.3670886
P/B ratio: 0.005622541695358236
Market cap (USD): 3235075.265822785
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 1.793558226203134
Free cash flow (dilution-adjusted): -6712658.227848101
Buyback yield (%): 0
Retained earnings: 165200000
Receivables turnover: 68.81818181818181
Capitalized R&D asset: 0
FCF margin (%): -5.6953528584163
Rule of 40 score: -5.6953528584163
Financial ratios for HANA.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 621657333.3333334
Buffett classification: The Gruesome
Stock price: 0.0292
Shares outstanding: 127785473
Book value: 621657333.3333334
P/B ratio: 0.006002238872647954
Market cap (USD): 3731335.8116
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 189605333.33333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HANA.L — annual report dated 2025-03-31
Total revenue: 15857142.857142856
Net income: 13345454.545454545
Capital expenditures: 0
Operating cash flow: 5831168.831168831
Net tangible assets: 598779220.7792208
Owner earnings: 13345454.545454545
Return on net tangible assets (%): 2.228777165661736
Buffett classification: The Gruesome
Stock price: 0.027662337662337663
P/E ratio: 0.26487257443557805
Shares outstanding: 127785473
Book value: 598779220.7792208
P/B ratio: 0.005903419457120548
Market cap (USD): 3534844.9024675325
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 15.225225225225225
Free cash flow (dilution-adjusted): 5831168.831168831
Buyback yield (%): 0
Receivables turnover: 120.8910891089109
Capitalized R&D asset: 0
FCF margin (%): 36.77313677313678
Revenue growth (%): -86.54601190284407
Rule of 40 score: -49.772875129707295
Financial ratios for HANA.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 598779220.7792208
Buffett classification: The Gruesome
Stock price: 0.027662337662337663
Shares outstanding: 127785473
Book value: 598779220.7792208
P/B ratio: 0.005903419457120548
Market cap (USD): 3534844.9024675325
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HMC — annual report dated 2022-03-31
Total revenue: 119264841829.20833
Gross profit: 24461342402.884773
Operating income: 7140075397.475823
Net income: 6234232093.099492
Capital expenditures: 1975372889.6902149
Operating cash flow: 13765136862.809376
Depreciation & amortization: 5007892148.828061
Net tangible assets: 78866718570.72612
Owner earnings: 9266751352.237339
Return on net tangible assets (%): 11.749888318133966
Capex to operating income (%): 27.665994821126866
Buffett classification: The Good
Stock price: 25.09
P/E ratio: 5.221965957811262
Shares outstanding: 1297526814
Book value: 88285084412.39142
P/B ratio: 0.3687479938422156
Market cap (USD): 32554947763.26
Debt to equity: 0.46268096696918254
Current ratio: 1.472491251830533
Quick ratio: 1.1529675159828654
Effective tax rate (%): 28.91907044543492
Interest coverage ratio: 51.653050334973614
COGS to revenue (%): 79.48989657998766
R&D to revenue (%): 5.408317469147985
SG&A to revenue (%): 9.115046449125302
Free cash flow (dilution-adjusted): 10083560072.119326
Buyback yield (%): 0
Retained earnings: 78176798885.42862
Inventory turnover: 6.029519720121676
Receivables turnover: 5.616890934010478
Capitalized R&D asset: 6450221275.200787
ROCI (R&D-adjusted, %): 7.442685759772571
FCF margin (%): 8.45476329609304
Rule of 40 score: 8.45476329609304
Financial ratios for HMC — annual report dated 2023-03-31
Total revenue: 126934872372.37239
Gross profit: 25011951951.951954
Operating income: 5861629129.129129
Net income: 5385202702.702703
Capital expenditures: 3444759759.75976
Operating cash flow: 15983648648.64865
Depreciation & amortization: 5417642642.642643
Net tangible assets: 77427552552.55257
Owner earnings: 7358085585.585587
Return on net tangible assets (%): 9.50318761605104
Capex to operating income (%): 58.76795825653939
Buffett classification: The Good
Stock price: 24.39
P/E ratio: 5.876599404062784
Shares outstanding: 1297526814
Book value: 86353536036.03604
P/B ratio: 0.36647809048900537
Market cap (USD): 31646678993.46
Debt to equity: 0.38026972191887687
Current ratio: 1.4398931829893733
Quick ratio: 1.114104908447287
Effective tax rate (%): 18.447300654300708
Interest coverage ratio: 21.620763181214002
COGS to revenue (%): 80.29544483364852
R&D to revenue (%): 5.210133237913439
SG&A to revenue (%): 9.876597827324492
Free cash flow (dilution-adjusted): 11235240240.240242
Buyback yield (%): 0
Retained earnings: 74925885885.8859
Inventory turnover: 6.264411789677295
Receivables turnover: 5.712524714808343
Capitalized R&D asset: 10935124230.360504
ROCI (R&D-adjusted, %): 5.5542158006477695
Rosenberg metric: 0.0853628930815309
FCF margin (%): 8.85118488738136
Revenue growth (%): 6.431091028609949
Rule of 40 score: 15.28227591599131
Financial ratios for HMC — annual report dated 2024-03-31
Total revenue: 134897002113.04808
Gross profit: 29134594558.901215
Operating income: 9125574484.944532
Net income: 7808967247.754887
Capital expenditures: 2207223983.0956154
Operating cash flow: 4934482303.222399
Depreciation & amortization: 5245417326.994189
Net tangible assets: 77240530903.32805
Owner earnings: 10847160591.653461
Return on net tangible assets (%): 14.043353230222413
Capex to operating income (%): 24.187233217340083
Buffett classification: The Great
Stock price: 35.58
P/E ratio: 5.911921842852258
Shares outstanding: 1297526814
Book value: 85881352350.76596
P/B ratio: 0.5375556250391096
Market cap (USD): 46166004042.119995
Debt to equity: 0.46578706910232553
Current ratio: 1.4263921921232097
Quick ratio: 1.1328892969441189
Effective tax rate (%): 27.99552358035636
Interest coverage ratio: 23.17547919706193
COGS to revenue (%): 78.40234096938235
R&D to revenue (%): 4.521200019462717
SG&A to revenue (%): 10.31161298641007
Free cash flow (dilution-adjusted): 915299788.6951928
Buyback yield (%): 0
Retained earnings: 70286667987.32172
Inventory turnover: 6.556226869845668
Receivables turnover: 5.377862965174255
Capitalized R&D asset: 12658565210.509916
ROCI (R&D-adjusted, %): 5.727027265491632
Rosenberg metric: 0.6233700132766969
FCF margin (%): 0.678517516592505
Revenue growth (%): 6.272610191246911
Rule of 40 score: 6.951127707839416
Financial ratios for HMC — quarterly report dated 2024-12-31
Total revenue: 35232256831.645325
Gross profit: 7514758901.840881
Operating income: 2530810879.6738644
Net income: 2124848716.4787564
Capital expenditures: 668106248.8056563
Operating cash flow: 539098031.7217656
Depreciation & amortization: 1153984330.2121153
Net tangible assets: 76477106822.09058
Owner earnings: 2610726797.8852153
Return on net tangible assets (%): 3.4137363537542993
Capex to operating income (%): 26.3989006121134
Buffett classification: The Good
Stock price: 27.84
P/E ratio: 4.250084514442789
Shares outstanding: 1297526814
Book value: 85171775272.31032
P/B ratio: 0.4241210939453528
Market cap (USD): 36123146501.76
Debt to equity: 0
Current ratio: 1.3844518342522698
Quick ratio: 1.0999968804751208
Effective tax rate (%): 31.02236117831458
Interest coverage ratio: 30.45469875824007
COGS to revenue (%): 78.67079892795518
R&D to revenue (%): 4.839442773894291
SG&A to revenue (%): 9.306537274963878
Free cash flow (dilution-adjusted): -694553793.2352378
Buyback yield (%): 0
Retained earnings: 70441888018.34511
Inventory turnover: 1.7352748467955574
Receivables turnover: 1.4284147809399454
Capitalized R&D asset: 1705044907.3189373
ROCI (R&D-adjusted, %): 2.5223535225471583
FCF margin (%): -1.971357658279203
Rule of 40 score: -1.971357658279203
Financial ratios for HMC — quarterly report dated 2025-03-31
Total revenue: 35824368399.94653
Gross profit: 7605854832.241678
Operating income: 491685603.52893996
Net income: 284768079.13380563
Capital expenditures: 1160767277.1019917
Operating cash flow: 927870605.5340195
Depreciation & amortization: 1302586552.5999198
Net tangible assets: 74859711268.54698
Owner earnings: 426587354.6317339
Return on net tangible assets (%): 0.5698490515164044
Capex to operating income (%): 236.07916700649758
Buffett classification: The Gruesome
Stock price: 27.13
P/E ratio: 30.90401017812066
Shares outstanding: 1297526814
Book value: 84399291538.56435
P/B ratio: 0.4170876534874145
Market cap (USD): 35201902463.82
Debt to equity: 0.35019784092617084
Current ratio: 1.356651074379724
Quick ratio: 1.0698785872387468
Effective tax rate (%): 53.72878226778597
Interest coverage ratio: 4.362051586125111
COGS to revenue (%): 78.7690469589604
R&D to revenue (%): 6.590713281724284
SG&A to revenue (%): 13.267750513895226
Free cash flow (dilution-adjusted): -1004658468.1192354
Buyback yield (%): 0
Retained earnings: 74336231787.19423
Inventory turnover: 1.7089253983866204
Receivables turnover: 1.368528233460917
Capitalized R&D asset: 3503461494.1328015
ROCI (R&D-adjusted, %): 0.9876162012725769
Rosenberg metric: 0.05342729098205326
FCF margin (%): -2.804399667017534
Revenue growth (%): 1.680595061311482
Rule of 40 score: -1.1238046057060522
Financial ratios for HMC — annual report dated 2025-03-31
Total revenue: 144959009490.7098
Gross profit: 31172162812.458225
Operating income: 8110453147.97487
Net income: 6035516642.160139
Capital expenditures: 3332074588.9586954
Operating cash flow: 1952626654.1906161
Depreciation & amortization: 4964997994.920465
Net tangible assets: 74859711268.54698
Owner earnings: 7668440048.121909
Return on net tangible assets (%): 10.243747829339915
Capex to operating income (%): 41.08370430313988
Buffett classification: The Good
Stock price: 27.13
P/E ratio: 5.832458851645395
Shares outstanding: 1297526814
Book value: 84399291538.56435
P/B ratio: 0.4170876534874145
Market cap (USD): 35201902463.82
Debt to equity: 0.35019784092617084
Current ratio: 1.356651074379724
Quick ratio: 1.0698785872387468
Effective tax rate (%): 31.46580249537051
Interest coverage ratio: 22.100752180960534
COGS to revenue (%): 78.49587761259087
R&D to revenue (%): 5.069361480991519
SG&A to revenue (%): 10.839763274694223
Free cash flow (dilution-adjusted): -3711288597.7810454
Buyback yield (%): 0
Retained earnings: 74336231787.19423
Inventory turnover: 6.89098069691855
Receivables turnover: 5.537585337662547
Capitalized R&D asset: 13617248663.900091
ROCI (R&D-adjusted, %): 5.423818587267747
Rosenberg metric: 0.33408436123962776
FCF margin (%): -2.5602331381954535
Revenue growth (%): 7.459029644876347
Rule of 40 score: 4.898796506680894
Financial ratios for HMC — quarterly report dated 2025-06-30
Total revenue: 36951757542.20869
Gross profit: 7409486576.252421
Operating income: 1689523941.3230002
Net income: 1486949903.1275947
Capital expenditures: 868557985.0539716
Operating cash flow: 592713811.237199
Depreciation & amortization: 1235898145.585386
Net tangible assets: 74284528092.9975
Owner earnings: 1854290063.659009
Return on net tangible assets (%): 2.4961995603412945
Capex to operating income (%): 51.40844493590531
Buffett classification: The Good
Stock price: 28.83
P/E ratio: 6.2893339528349355
Shares outstanding: 1297526814
Book value: 83468032106.28285
P/B ratio: 0.4481679644727628
Market cap (USD): 37407698047.619995
Debt to equity: 0
Current ratio: 1.2964960824464715
Quick ratio: 1.0134621515537876
Effective tax rate (%): 26.49024745667627
Interest coverage ratio: 17.55987055016181
COGS to revenue (%): 79.94821608203934
R&D to revenue (%): 5.485548665347881
SG&A to revenue (%): 9.993992810847697
Free cash flow (dilution-adjusted): -793903957.9296982
Buyback yield (%): 0
Retained earnings: 77164046498.75449
Inventory turnover: 1.8065685492947974
Receivables turnover: 1.4336239900370817
Capitalized R&D asset: 4171596004.2679696
ROCI (R&D-adjusted, %): 1.1008276978159104
Rosenberg metric: -0.0831687782857419
FCF margin (%): -2.148487678895516
Revenue growth (%): 3.1469895845081703
Rule of 40 score: 0.9985019056126543
Financial ratios for HMC — quarterly report dated 2025-09-30
Total revenue: 35615154777.92732
Gross profit: 7255053835.800808
Operating income: 1305343203.230148
Net income: 900148048.4522208
Capital expenditures: 645255720.0538359
Operating cash flow: 1885612382.2341857
Depreciation & amortization: 2021608344.5491252
Net tangible assets: 73436581426.64873
Owner earnings: 2276500672.9475102
Return on net tangible assets (%): 3.0999545849249075
Capex to operating income (%): 49.43188262344439
Buffett classification: The Good
Stock price: 30.8
P/E ratio: 8.331499365183578
Shares outstanding: 1297526814
Book value: 82364623149.39435
P/B ratio: 0.4852062007096534
Market cap (USD): 39963825871.200005
Debt to equity: 0
Current ratio: 1.4134040362012847
Quick ratio: 1.1256973055597361
Effective tax rate (%): 43.10058064104473
Interest coverage ratio: 12.560642362235317
COGS to revenue (%): 79.62930701540243
R&D to revenue (%): 5.504238899012397
SG&A to revenue (%): 11.201319927473524
Free cash flow (dilution-adjusted): 780363391.6554509
Buyback yield (%): 0
Retained earnings: 75855942126.51413
Inventory turnover: 1.7289672542013799
Receivables turnover: 1.386485854203447
Capitalized R&D asset: 4097594517.880829
ROCI (R&D-adjusted, %): 0.7229630190382401
Rosenberg metric: -0.07618758478634811
FCF margin (%): 2.1910992568227874
Revenue growth (%): -3.6171561332491704
Rule of 40 score: -1.426056876426383
Financial ratios for HMC — quarterly report dated 2025-12-31
Total revenue: 34160117639.537113
Gross profit: 6918847899.750655
Operating income: 980506361.4858385
Net income: 1090409820.343968
Capital expenditures: 931685953.5835304
Operating cash flow: 1993970973.7229078
Depreciation & amortization: 1129640048.5902436
Net tangible assets: 73087488012.27544
Owner earnings: 1288363915.3506813
Return on net tangible assets (%): 1.76276945670139
Capex to operating income (%): 95.02089840311422
Buffett classification: The Gruesome
Stock price: 29.48
P/E ratio: 10.167008478649295
Shares outstanding: 1297526814
Book value: 81698484751.61435
P/B ratio: 0.4681982853539296
Market cap (USD): 38251090476.72
Debt to equity: 0
Current ratio: 1.3609867990609246
Quick ratio: 1.0942918721581694
Effective tax rate (%): 30.207310286125843
Interest coverage ratio: 11.102656917396656
COGS to revenue (%): 79.7458311685006
R&D to revenue (%): 6.017461403590204
SG&A to revenue (%): 11.366382530810498
Free cash flow (dilution-adjusted): 624461351.5759861
Buyback yield (%): 0
Retained earnings: 72203695415.89412
Inventory turnover: 1.756789675001866
Receivables turnover: 1.3087539317236485
Capitalized R&D asset: 4037914032.628495
ROCI (R&D-adjusted, %): 0.6553275818020926
Rosenberg metric: -0.17150360992716515
FCF margin (%): 1.8280421577156134
Revenue growth (%): -4.085443815877998
Rule of 40 score: -2.2574016581623844
Financial ratios for HUW.L — annual report dated 2021-12-31
Capital expenditures: 4032432.4324324327
Buffett classification: The Gruesome
Stock price: 0.019324324324324325
Shares outstanding: 69002297
Market cap (USD): 1333422.7663513513
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HUW.L — annual report dated 2022-12-31
Total revenue: 179985542.1686747
Net income: -2531325.301204819
Capital expenditures: 838554.21686747
Operating cash flow: -32574698.795180723
Depreciation & amortization: -1465060.2409638555
Net tangible assets: 67161445.78313254
Owner earnings: -4834939.759036145
Return on net tangible assets (%): -7.198981056257176
Buffett classification: The Gruesome
Stock price: 0.017108433734939758
Shares outstanding: 69002297
Book value: 138697590.36144578
P/B ratio: 0.008511476102120415
Market cap (USD): 1180521.2257831325
Debt to equity: 0.13029995048601883
COGS to revenue (%): 0
SG&A to revenue (%): 11.552467400326666
Free cash flow (dilution-adjusted): -33413253.012048196
Buyback yield (%): 0
Retained earnings: -2606024.0963855423
Receivables turnover: 1.1992678580029863
Capitalized R&D asset: 0
FCF margin (%): -18.564409457252257
Rule of 40 score: -18.564409457252257
Financial ratios for HUW.L — annual report dated 2023-12-31
Total revenue: 271830379.7468354
Net income: 20722784.81012658
Capital expenditures: 632911.3924050633
Operating cash flow: 4054430.379746835
Depreciation & amortization: -783544.3037974683
Net tangible assets: 73397468.35443038
Owner earnings: 19306329.11392405
Return on net tangible assets (%): 26.303807947019862
Buffett classification: The Gruesome
Stock price: 0.01708860759493671
P/E ratio: 0.05690128944474987
Shares outstanding: 69002297
Book value: 177343037.97468352
P/B ratio: 0.006648996149206644
Market cap (USD): 1179153.1765822785
Debt to equity: 0.4215173339233839
Effective tax rate (%): 27.896939000220218
COGS to revenue (%): 0
SG&A to revenue (%): 11.657027371871887
Free cash flow (dilution-adjusted): 3421518.987341772
Buyback yield (%): 344.48665339894944
Retained earnings: 10987341.772151899
Receivables turnover: 1.4419935134264015
Capitalized R&D asset: 0
FCF margin (%): 1.2586963203039871
Revenue growth (%): 51.02900848118549
Rule of 40 score: 52.28770480148948
Financial ratios for HUW.L — annual report dated 2024-12-31
Total revenue: 44731250
Net income: 23218750
Capital expenditures: 0
Operating cash flow: -4595000
Net tangible assets: 216395000
Owner earnings: 23218750
Return on net tangible assets (%): 10.7297996718963
Buffett classification: The Gruesome
Stock price: 0.030999999999999996
P/E ratio: 0.0921268891305518
Shares outstanding: 69002297
Book value: 216395000
P/B ratio: 0.009885030647658216
Market cap (USD): 2139071.207
Debt to equity: 0.33767531597310474
Effective tax rate (%): 11.24755124468441
COGS to revenue (%): 0
SG&A to revenue (%): 9.177029481626379
Free cash flow (dilution-adjusted): -4595000
Buyback yield (%): 264.65925872284436
Retained earnings: 92377500
Capitalized R&D asset: 0
FCF margin (%): -10.272460528154255
Revenue growth (%): -83.54442574017676
Rule of 40 score: -93.81688626833102
Financial ratios for HUW.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 216395000
Buffett classification: The Gruesome
Stock price: 0.030999999999999996
Shares outstanding: 69002297
Book value: 216395000
P/B ratio: 0.009885030647658216
Market cap (USD): 2139071.207
Debt to equity: 0.33767531597310474
Buyback yield (%): 0
Retained earnings: 92377500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HUW.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.029589041095890414
Shares outstanding: 69002297
Market cap (USD): 2041711.8016438358
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYMC — annual report dated 2021-12-31
Gross profit: -52604000
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.14
Shares outstanding: 91360601
Market cap (USD): 560954090.14
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYMC — annual report dated 2022-12-31
Total revenue: 33229000
Gross profit: -15659000
Operating income: -53490000
Net income: -60828000
Capital expenditures: 1763000
Operating cash flow: -34855000
Depreciation & amortization: 3356000
Net tangible assets: 63306000
Owner earnings: -59235000
Return on net tangible assets (%): -93.56932992133447
Buffett classification: The Gruesome
Stock price: 5.32
Shares outstanding: 91360601
Book value: 63306000
P/B ratio: 7.677603976242379
Market cap (USD): 486038397.32000005
Debt to equity: 2.132957381606799
Current ratio: 12.664505941992854
Quick ratio: 12.431147677220975
Interest coverage ratio: -3.0064073741007196
COGS to revenue (%): 147.12449968401097
SG&A to revenue (%): 43.23632971199856
Free cash flow (dilution-adjusted): -38275000
Buyback yield (%): 0
Retained earnings: -670151000
Inventory turnover: 17.41025641025641
Receivables turnover: 6.980882352941176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.577145968487386
FCF margin (%): -115.18553071112582
Rule of 40 score: -115.18553071112582
Financial ratios for HYMC — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -45554000
Net income: -55024000
Capital expenditures: 1070000
Operating cash flow: -41448000
Depreciation & amortization: 3309000
Net tangible assets: 12656000
Owner earnings: -52785000
Return on net tangible assets (%): -417.07490518331224
Buffett classification: The Gruesome
Stock price: 2.45
Shares outstanding: 91360601
Book value: 12656000
P/B ratio: 17.685957051991153
Market cap (USD): 223833472.45000002
Debt to equity: 11.455436156763591
Current ratio: 9.66856802315682
Quick ratio: 9.512429763323684
Interest coverage ratio: -2.5302155076649635
Free cash flow (dilution-adjusted): -45438000
Buyback yield (%): 0
Retained earnings: -725175000
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.98247932317962
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for HYMC — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 523000
Buffett classification: The Gruesome
Stock price: 2.5
Shares outstanding: 91360601
Market cap (USD): 228401502.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYMC — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -12119000
Operating income: -53183000
Net income: -60896000
Capital expenditures: 1253000
Operating cash flow: -35897000
Depreciation & amortization: 2233000
Net tangible assets: -33415000
Owner earnings: -59916000
Buffett classification: The Gruesome
Stock price: 2.21
Shares outstanding: 91360601
Book value: -33415000
Market cap (USD): 201906928.21
Debt to equity: -3.741074367798893
Current ratio: 9.423541594753193
Quick ratio: 9.189851570590266
Interest coverage ratio: -2.6831643206699964
Free cash flow (dilution-adjusted): -39777000
Buyback yield (%): 0
Retained earnings: -786066000
Inventory turnover: 8.950516986706056
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -39.58806321227325
Rule of 40 score: 0
Financial ratios for HYMC — quarterly report dated 2024-12-31
Gross profit: -3613000
Capital expenditures: 0
Depreciation & amortization: 1058000
Buffett classification: The Gruesome
Stock price: 2.21
Shares outstanding: 91360601
Market cap (USD): 201906928.21
Buyback yield (%): 0
Inventory turnover: 2.6683899556868536
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYMC — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -534000
Operating income: -9279000
Net income: -11759000
Capital expenditures: 171000
Operating cash flow: -9695000
Depreciation & amortization: 545000
Net tangible assets: -44506000
Owner earnings: -11385000
Buffett classification: The Gruesome
Stock price: 3.24
Shares outstanding: 91360601
Book value: -44506000
Market cap (USD): 296008347.24
Debt to equity: -2.877342380802588
Current ratio: 16.167891256429098
Quick ratio: 15.6895664952241
Interest coverage ratio: -2.762429294432867
Free cash flow (dilution-adjusted): -10394000
Buyback yield (%): 0
Retained earnings: -797825000
Inventory turnover: 0.41013824884792627
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.329094427550255
Rule of 40 score: 0
Financial ratios for HYMC — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -3171000
Operating income: -9326000
Net income: -11737000
Capital expenditures: 226000
Operating cash flow: -9023000
Depreciation & amortization: 498000
Net tangible assets: -15259000
Owner earnings: -11465000
Buffett classification: The Gruesome
Stock price: 3.13
Shares outstanding: 91360601
Book value: -15259000
Market cap (USD): 285958681.13
Debt to equity: -8.590929942984468
Current ratio: 25.800965850293206
Quick ratio: 25.3487409451535
Interest coverage ratio: -2.7078977932636468
Free cash flow (dilution-adjusted): -9885000
Buyback yield (%): 0
Retained earnings: -809562000
Inventory turnover: 2.4187643020594964
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.856274490103487
Rule of 40 score: 0
Financial ratios for HYMC — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -502000
Operating income: -7258000
Net income: -9376000
Capital expenditures: 50000
Operating cash flow: -3439000
Depreciation & amortization: 502000
Net tangible assets: 47485000
Owner earnings: -8924000
Return on net tangible assets (%): -18.793303148362643
Buffett classification: The Gruesome
Stock price: 6.2
Shares outstanding: 91360601
Book value: 47485000
P/B ratio: 11.928729624091819
Market cap (USD): 566435726.2
Debt to equity: 2.826892702958829
Current ratio: 19.03874852729415
Quick ratio: 18.866474669459354
Interest coverage ratio: -2.0572562358276643
Free cash flow (dilution-adjusted): -3855000
Buyback yield (%): 0
Retained earnings: -818938000
Inventory turnover: 0.38145896656534956
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.25540923606875
Rule of 40 score: 0
Financial ratios for HYMC — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -18776000
Net income: -7792000
Capital expenditures: 117000
Operating cash flow: -60717000
Depreciation & amortization: 490000
Net tangible assets: 213695000
Owner earnings: -7419000
Return on net tangible assets (%): -3.4717705140503994
Buffett classification: The Gruesome
Stock price: 23.77
Shares outstanding: 91360601
Book value: 213695000
P/B ratio: 10.16234112061583
Market cap (USD): 2171641485.77
Debt to equity: 0.00018250310021292028
Current ratio: 24.242565296095165
Quick ratio: 24.059477631238686
Interest coverage ratio: -32.261168384879724
Free cash flow (dilution-adjusted): -61200000
Buyback yield (%): 0
Retained earnings: -826730000
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.354686575816806
Rule of 40 score: 0
Financial ratios for HYMC — annual report dated 2025-12-31
Total revenue: 0
Operating income: -44639000
Net income: -40664000
Capital expenditures: 564000
Operating cash flow: -82874000
Depreciation & amortization: 2024000
Net tangible assets: 213695000
Owner earnings: -39204000
Return on net tangible assets (%): -18.345773181403402
Buffett classification: The Gruesome
Stock price: 23.77
Shares outstanding: 91360601
Book value: 213695000
P/B ratio: 10.16234112061583
Market cap (USD): 2171641485.77
Debt to equity: 0.00018250310021292028
Current ratio: 24.242565296095165
Quick ratio: 24.059477631238686
Interest coverage ratio: -4.090067802822063
Free cash flow (dilution-adjusted): -85334000
Buyback yield (%): 0
Retained earnings: -826730000
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.485399129627528
Rule of 40 score: 0
Financial ratios for JBSS — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 72.85
Shares outstanding: 9092149
Market cap (USD): 662363054.65
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JBSS — annual report dated 2022-06-30
Total revenue: 955868000
Gross profit: 199627000
Operating income: 83741000
Net income: 61787000
Capital expenditures: 17754000
Operating cash flow: 19604000
Depreciation & amortization: 19711000
Net tangible assets: 261106000
Owner earnings: 63744000
Return on net tangible assets (%): 24.41307361761124
Capex to operating income (%): 21.2010842956258
Buffett classification: The Great
Stock price: 61.62
P/E ratio: 9.067574431191026
Shares outstanding: 9092149
Book value: 278821000
P/B ratio: 2.009383157581387
Market cap (USD): 560258221.38
Debt to equity: 0.18883800000717307
Current ratio: 2.3066095371531907
Quick ratio: 0.6378928332871736
Effective tax rate (%): 24.369614179396788
Interest coverage ratio: 43.592399791775115
COGS to revenue (%): 79.11563102855206
SG&A to revenue (%): 12.123640502663548
Free cash flow (dilution-adjusted): -1715000
Buyback yield (%): 0
Retained earnings: 153589000
Inventory turnover: 3.6915916135803375
Receivables turnover: 13.731565413512232
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.80616332819723
FCF margin (%): -0.17941807864684245
Rule of 40 score: -0.17941807864684245
Financial ratios for JBSS — annual report dated 2023-06-30
Total revenue: 999686000
Gross profit: 211631000
Operating income: 88903000
Net income: 62857000
Capital expenditures: 20732000
Operating cash flow: 124655000
Depreciation & amortization: 22138000
Net tangible assets: 273799000
Owner earnings: 64263000
Return on net tangible assets (%): 23.470867315074198
Capex to operating income (%): 23.319797982070348
Buffett classification: The Great
Stock price: 105.41
P/E ratio: 15.247361886345196
Shares outstanding: 9092149
Book value: 292207000
P/B ratio: 3.27987839473387
Market cap (USD): 958403426.0899999
Debt to equity: 0.04390723014849063
Current ratio: 2.969260573242461
Quick ratio: 0.9510549901969938
Effective tax rate (%): 26.353837141183362
Interest coverage ratio: 41.177860120426125
COGS to revenue (%): 78.8302526993476
SG&A to revenue (%): 12.276654869629064
Free cash flow (dilution-adjusted): 100358000
Buyback yield (%): 0
Retained earnings: 161512000
Inventory turnover: 4.556917009760836
Receivables turnover: 13.744411141969367
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.17881678096814
FCF margin (%): 10.038952231000534
Revenue growth (%): 4.584105755187955
Rule of 40 score: 14.623057986188488
Financial ratios for JBSS — annual report dated 2024-06-30
Total revenue: 1066783000
Gross profit: 214139000
Operating income: 81660000
Net income: 60249000
Capital expenditures: 28312000
Operating cash flow: 101673000
Depreciation & amortization: 26604000
Net tangible assets: 305041000
Owner earnings: 58541000
Return on net tangible assets (%): 19.191190692398727
Capex to operating income (%): 34.67058535390644
Buffett classification: The Good
Stock price: 89.96
P/E ratio: 13.575822404355259
Shares outstanding: 9092149
Book value: 322613000
P/B ratio: 2.5353278511405306
Market cap (USD): 817929724.04
Debt to equity: 0.16410993977304075
Current ratio: 2.3351198983643005
Quick ratio: 0.7743528664443385
Effective tax rate (%): 24.629395649073647
Interest coverage ratio: 32.03609258532758
COGS to revenue (%): 79.926657998862
SG&A to revenue (%): 12.418551851688676
Free cash flow (dilution-adjusted): 68972000
Buyback yield (%): 0
Retained earnings: 186965000
Inventory turnover: 4.337764482634066
Receivables turnover: 12.556297080979284
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.95807614818997
FCF margin (%): 6.465419865145957
Revenue growth (%): 6.711807507557372
Rule of 40 score: 13.17722737270333
Financial ratios for JBSS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 89.15
Shares outstanding: 9092149
Market cap (USD): 810565083.35
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JBSS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 82.34
Shares outstanding: 9092149
Market cap (USD): 748647548.6600001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JBSS — quarterly report dated 2025-03-31
Total revenue: 260907000
Gross profit: 55893000
Operating income: 27559000
Net income: 20153000
Capital expenditures: 11679000
Operating cash flow: -25902000
Depreciation & amortization: 7903000
Net tangible assets: 330123000
Owner earnings: 16377000
Return on net tangible assets (%): 4.960878218118701
Capex to operating income (%): 42.37817047062666
Buffett classification: The Good
Stock price: 66.98
P/E ratio: 7.55460899146529
Shares outstanding: 9092149
Book value: 346613000
P/B ratio: 1.7569800902447401
Market cap (USD): 608992140.02
Debt to equity: 0.35314024574958236
Current ratio: 2.006977372392825
Quick ratio: 0.5253030329154956
Effective tax rate (%): 22.909494300359576
Interest coverage ratio: 26.12227488151659
COGS to revenue (%): 78.57742413963597
SG&A to revenue (%): 10.859808284177888
Free cash flow (dilution-adjusted): -38416000
Buyback yield (%): 0
Retained earnings: 207968000
Inventory turnover: 0.7952505450003491
Receivables turnover: 3.500321983417854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.624998497541979
FCF margin (%): -14.724020436400709
Rule of 40 score: -14.724020436400709
Financial ratios for JBSS — annual report dated 2025-06-30
Total revenue: 1107246000
Gross profit: 203471000
Operating income: 82862000
Net income: 58934000
Capital expenditures: 50712000
Operating cash flow: 30545000
Depreciation & amortization: 31469000
Net tangible assets: 344519000
Owner earnings: 39691000
Return on net tangible assets (%): 11.520699874317526
Capex to operating income (%): 61.200550312567884
Buffett classification: The Good
Stock price: 59.78
P/E ratio: 9.222667173787627
Shares outstanding: 9092149
Book value: 360697000
P/B ratio: 1.5068843578405144
Market cap (USD): 543528667.22
Debt to equity: 0.2706066310504385
Current ratio: 2.2200120477295155
Quick ratio: 0.5884418697050869
Effective tax rate (%): 24.312592307198354
Interest coverage ratio: 23.328265765765767
COGS to revenue (%): 81.62368615465759
SG&A to revenue (%): 10.892701350919308
Free cash flow (dilution-adjusted): -24690000
Buyback yield (%): 0
Retained earnings: 221495000
Inventory turnover: 3.5497839748625295
Receivables turnover: 14.444348778960551
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.765867147389805
FCF margin (%): -2.2298567797941917
Revenue growth (%): 3.7929925767470984
Rule of 40 score: 1.5631357969529067
Financial ratios for JBSS — quarterly report dated 2025-06-30
Total revenue: 269076000
Gross profit: 48783000
Operating income: 19685000
Net income: 13527000
Capital expenditures: 13485000
Operating cash flow: 36531000
Depreciation & amortization: 8228000
Net tangible assets: 344519000
Owner earnings: 8270000
Return on net tangible assets (%): 2.400448161059332
Capex to operating income (%): 68.50393700787401
Buffett classification: The Good
Stock price: 59.78
P/E ratio: 16.138024561163895
Shares outstanding: 9092149
Book value: 360697000
P/B ratio: 1.5068843578405144
Market cap (USD): 543528667.22
Debt to equity: 0.2706066310504385
Current ratio: 2.2200120477295155
Quick ratio: 0.5884418697050869
Effective tax rate (%): 25.327077008004416
Interest coverage ratio: 16.28205128205128
COGS to revenue (%): 81.8701779422914
SG&A to revenue (%): 10.814045102498921
Free cash flow (dilution-adjusted): 22009000
Buyback yield (%): 0
Retained earnings: 221495000
Inventory turnover: 0.8652513747054202
Receivables turnover: 3.51017532874139
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.458088083758156
FCF margin (%): 8.179473457313176
Revenue growth (%): 3.1310007013993495
Rule of 40 score: 11.310474158712525
Financial ratios for JBSS — quarterly report dated 2025-09-30
Total revenue: 298683000
Gross profit: 54094000
Operating income: 26441000
Net income: 18726000
Capital expenditures: 24878000
Operating cash flow: 32134000
Depreciation & amortization: 8368000
Net tangible assets: 346918000
Owner earnings: 2216000
Return on net tangible assets (%): 0.6387676626753296
Capex to operating income (%): 94.08872584244166
Buffett classification: The Gruesome
Stock price: 62.23
P/E ratio: 10.796558261840246
Shares outstanding: 9092149
Book value: 362784000
P/B ratio: 1.5596179331778688
Market cap (USD): 565804432.27
Debt to equity: 0.2958316794566464
Current ratio: 2.4403339455180033
Quick ratio: 0.7229291207223292
Effective tax rate (%): 25.29918621349928
Interest coverage ratio: 26.870934959349594
COGS to revenue (%): 81.8891600794153
SG&A to revenue (%): 9.258310650422018
Free cash flow (dilution-adjusted): 6402000
Buyback yield (%): 0
Retained earnings: 222728000
Inventory turnover: 1.0420636002658532
Receivables turnover: 3.540240375497819
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.722999136387937
FCF margin (%): 2.1434095680035354
Revenue growth (%): 11.003210988716942
Rule of 40 score: 13.146620556720478
Financial ratios for JBSS — quarterly report dated 2025-12-31
Total revenue: 314777000
Gross profit: 59169000
Operating income: 25401000
Net income: 17957000
Capital expenditures: 22445000
Operating cash flow: 62491000
Depreciation & amortization: 8286000
Net tangible assets: 354564000
Owner earnings: 3798000
Return on net tangible assets (%): 1.0711747385521373
Capex to operating income (%): 88.3626628872879
Buffett classification: The Gruesome
Stock price: 69.3
P/E ratio: 8.954790524849708
Shares outstanding: 9092149
Book value: 370124000
P/B ratio: 1.7023644121969932
Market cap (USD): 630085925.6999999
Debt to equity: 0.18338448736099253
Current ratio: 2.2722531434039057
Quick ratio: 0.6858819724269908
Effective tax rate (%): 26.73303684360847
Interest coverage ratio: 50.49900596421471
COGS to revenue (%): 81.20288331104241
SG&A to revenue (%): 10.727594455757568
Free cash flow (dilution-adjusted): 38576000
Buyback yield (%): 0
Retained earnings: 228981000
Inventory turnover: 1.0857208391560866
Receivables turnover: 3.9434373551482653
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.412264048427202
FCF margin (%): 12.255024985942429
Revenue growth (%): 5.38832139760214
Rule of 40 score: 17.643346383544568
Financial ratios for JEMI.L — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.01611111111111111
Shares outstanding: 258726421
Market cap (USD): 4168370.116111111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JEMI.L — annual report dated 2022-07-31
Total revenue: -19731707.31707317
Net income: -24752439.024390247
Capital expenditures: 0
Operating cash flow: 17856097.56097561
Net tangible assets: 507969512.195122
Owner earnings: -24752439.024390247
Return on net tangible assets (%): -4.872819811060295
Buffett classification: The Gruesome
Stock price: 0.012804878048780489
Shares outstanding: 258726421
Book value: 507969512.195122
P/B ratio: 0.006521966750693219
Market cap (USD): 3312960.268902439
Debt to equity: 0.07891293648793019
Free cash flow (dilution-adjusted): 17856097.56097561
Buyback yield (%): 18.883708385214685
Receivables turnover: -1.8910705937353902
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JEMI.L — annual report dated 2023-07-31
Total revenue: 50923076.92307692
Net income: 47675641.025641024
Capital expenditures: 0
Operating cash flow: 21470512.82051282
Net tangible assets: 561341025.6410257
Owner earnings: 47675641.025641024
Return on net tangible assets (%): 8.493168831050186
Buffett classification: The Gruesome
Stock price: 0.015128205128205128
P/E ratio: 0.08209782364267082
Shares outstanding: 258726421
Book value: 561341025.6410257
P/B ratio: 0.006972706768589869
Market cap (USD): 3914066.368974359
Debt to equity: 0.07100213317011003
Effective tax rate (%): 4.563069421275504
COGS to revenue (%): 0
SG&A to revenue (%): 1.8504531722054378
Free cash flow (dilution-adjusted): 21470512.82051282
Buyback yield (%): 14.674226755880976
Receivables turnover: 11.709905660377357
Capitalized R&D asset: 0
FCF margin (%): 42.162638469285
Rule of 40 score: 42.162638469285
Financial ratios for JEMI.L — annual report dated 2024-07-31
Total revenue: 37555128.2051282
Net income: 32597435.897435896
Capital expenditures: 0
Operating cash flow: 19830769.230769232
Net tangible assets: 562338461.5384616
Owner earnings: 32597435.897435896
Return on net tangible assets (%): 5.796764426935142
Buffett classification: The Gruesome
Stock price: 0.016025641025641028
P/E ratio: 0.12719579416738774
Shares outstanding: 258726421
Book value: 562338461.5384614
P/B ratio: 0.007373240548852779
Market cap (USD): 4146256.7467948725
Debt to equity: 0.07099930692346977
Effective tax rate (%): 10.339234078566895
COGS to revenue (%): 0
SG&A to revenue (%): 3.0553374526337356
Free cash flow (dilution-adjusted): 19830769.230769232
Buyback yield (%): 279.27569098171074
Receivables turnover: 10.446861626248216
Capitalized R&D asset: 0
FCF margin (%): 52.80442426518282
Revenue growth (%): -26.251258811681776
Rule of 40 score: 26.55316545350104
Financial ratios for JEMI.L — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 549333750
Buffett classification: The Gruesome
Stock price: 0.016125
Shares outstanding: 258726421
Market cap (USD): 4171963.538625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JEMI.L — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 599362666.6666666
Buffett classification: The Gruesome
Stock price: 0.019466666666666667
Shares outstanding: 258726421
Book value: 599362666.6666666
P/B ratio: 0.008403161016813416
Market cap (USD): 5036540.995466666
Debt to equity: 0.06724031304363302
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JEMI.L — annual report dated 2025-07-31
Total revenue: 74906666.66666667
Net income: 71601333.33333333
Capital expenditures: 0
Operating cash flow: 20340000
Net tangible assets: 599362666.6666666
Owner earnings: 71601333.33333333
Return on net tangible assets (%): 11.946245122596892
Buffett classification: The Gruesome
Stock price: 0.019466666666666667
P/E ratio: 0.07034144143684475
Shares outstanding: 258726421
Book value: 599362666.6666666
P/B ratio: 0.008403161016813416
Market cap (USD): 5036540.995466666
Debt to equity: 0.06724031304363302
Effective tax rate (%): 2.7701834114899246
COGS to revenue (%): 0
SG&A to revenue (%): 1.6358134567461726
Free cash flow (dilution-adjusted): 20340000
Buyback yield (%): 711.9171676012085
Receivables turnover: 43.348765432098766
Capitalized R&D asset: 0
FCF margin (%): 27.15379138483446
Revenue growth (%): 99.4578909637115
Rule of 40 score: 126.61168234854597
Financial ratios for KALA — annual report dated 2021-12-31
Gross profit: 7143000
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3025
Shares outstanding: 18589787
Market cap (USD): 56234105675
Buyback yield (%): 0
Inventory turnover: 0.4742447042481769
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KALA — annual report dated 2022-12-31
Total revenue: 3892000
Gross profit: 1332000
Operating income: -81356000
Net income: -44822000
Capital expenditures: 199000
Operating cash flow: -78908000
Depreciation & amortization: 537000
Net tangible assets: 18974000
Owner earnings: -44484000
Return on net tangible assets (%): -234.44713818910085
Buffett classification: The Gruesome
Stock price: 1907.5
Shares outstanding: 18589787
Book value: 18974000
P/B ratio: 1868.8741805892273
Market cap (USD): 35460018702.5
Debt to equity: 2.2636239063982293
Current ratio: 3.345999610667705
Quick ratio: 3.345999610667705
Interest coverage ratio: -11.19680704651803
COGS to revenue (%): 65.775950668037
R&D to revenue (%): 453.57142857142856
SG&A to revenue (%): 1670.9917780061667
Free cash flow (dilution-adjusted): -86229000
Buyback yield (%): 0
Retained earnings: -587210000
Receivables turnover: 0.5990457134061875
Capitalized R&D asset: 17653000
ROCI (R&D-adjusted, %): -88.32224873500193
FCF margin (%): -2215.5447070914697
Rule of 40 score: -2215.5447070914697
Financial ratios for KALA — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -34328000
Net income: -42199000
Capital expenditures: 563000
Operating cash flow: -27927000
Depreciation & amortization: 303000
Net tangible assets: 7504000
Owner earnings: -42459000
Return on net tangible assets (%): -565.8182302771854
Buffett classification: The Gruesome
Stock price: 350
Shares outstanding: 18589787
Book value: 7504000
P/B ratio: 867.0609608208955
Market cap (USD): 6506425450
Debt to equity: 4.840485074626866
Current ratio: 6.33477114785526
Quick ratio: 6.33477114785526
Interest coverage ratio: -5.904368765049879
Free cash flow (dilution-adjusted): -36000000
Buyback yield (%): 0
Retained earnings: -629409000
Receivables turnover: 0
Capitalized R&D asset: 30413510
ROCI (R&D-adjusted, %): -35.66125511980306
Rosenberg metric: -0.07545459695235937
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for KALA — quarterly report dated 2024-09-30
Capital expenditures: 90000
Buffett classification: The Gruesome
Stock price: 285
Shares outstanding: 18589787
Market cap (USD): 5298089295
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KALA — annual report dated 2024-12-31
Total revenue: 0
Operating income: -34235000
Net income: -38511000
Capital expenditures: 208000
Operating cash flow: -29382000
Depreciation & amortization: 259000
Net tangible assets: 12332000
Owner earnings: -38460000
Return on net tangible assets (%): -311.8715536814791
Buffett classification: The Gruesome
Stock price: 347
Shares outstanding: 18589787
Book value: 12332000
P/B ratio: 523.0827188614986
Market cap (USD): 6450656089
Debt to equity: 2.615309763217645
Current ratio: 3.113765038924275
Quick ratio: 3.113765038924275
Interest coverage ratio: -5.919937748573405
Free cash flow (dilution-adjusted): -37979000
Buyback yield (%): 0
Retained earnings: -667920000
Capitalized R&D asset: 40372110
ROCI (R&D-adjusted, %): -40.03255972511393
Rule of 40 score: 0
Financial ratios for KALA — quarterly report dated 2024-12-31
Capital expenditures: 69000
Buffett classification: The Gruesome
Stock price: 347
Shares outstanding: 18589787
Market cap (USD): 6450656089
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KALA — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -8298000
Net income: -8947000
Capital expenditures: 0
Operating cash flow: -8824000
Depreciation & amortization: 68000
Net tangible assets: 5708000
Owner earnings: -8879000
Return on net tangible assets (%): -155.55360896986684
Buffett classification: The Gruesome
Stock price: 286.5
Shares outstanding: 18589787
Book value: 5708000
P/B ratio: 933.0718247196917
Market cap (USD): 5325973975.5
Debt to equity: 5.667309039943938
Current ratio: 1.9898585418933623
Quick ratio: 1.9898585418933623
Interest coverage ratio: -7.605866177818515
Free cash flow (dilution-adjusted): -11134000
Buyback yield (%): 0
Retained earnings: -676867000
Receivables turnover: 0
Capitalized R&D asset: 6055000
ROCI (R&D-adjusted, %): -13.60057874803183
Rule of 40 score: 0